Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Agkistrodon halys venom toxins are a complex mixture of bioactive proteins and peptides produced by the Siberian pit viper (Agkistrodon halys, also known as Gloydius halys) (Biochem J, 2004; Reptile Database). These toxins primarily target the hemostatic and nervous systems, leading to symptoms such as local tissue damage, systemic hemorrhage, and occasionally neurotoxicity (HKMJ, 2016; ResearchGate, 2026). The venom contains several major classes of proteins, including phospholipase A2 (PLA2), snake venom metalloproteinases (SVMPs), serine proteases, and disintegrins (Biochem J, 2004; MDPI, 2024). While these components are responsible for the pathological effects of envenomation, they are also of significant interest in pharmacology; for instance, disintegrins like agkistrostatin are studied for their ability to inhibit platelet aggregation, and protein C activators are explored for antithrombotic therapy (PMC, 2011; MDPI, 2024). Clinical management of envenomation involves the use of specific antivenoms that neutralize these toxins, alongside supportive care to manage complications like coagulopathy and organ failure (HKMJ, 2016; Taylor & Francis, 2022). Research into these toxins continues to provide insights into the development of novel anticoagulants and anti-cancer agents (PMC, 2018; PMC, 2011).
Antibody-mediated neutralization of toxic components; competitive inhibition of phospholipase A2 activity; chelation of zinc ions in metalloproteinases.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Agkistrodon halys venom toxins (AhV).